![Eugene Kennedy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eugene Kennedy
Directeur Technique/Scientifique/R&D chez
PERCHERON THERAPEUTICS LIMITED
Profil
Dr. Eugene P.
Kennedy, MD, is a Chief Medical Officer at Percheron Therapeutics Ltd., a Member at American Society of Clinical Oncology, Inc. and a Member at The American Association of Cancer Research.
Dr. Kennedy was previously employed as a Chief Medical Officer by Carisma Therapeutics, Inc., a Chief Medical Officer by Galera Therapeutics, Inc. (US), a Chief Medical Officer by NewLink Genetics Corp., a Chief Medical Officer by Lumos Pharma, Inc., an Associate Professor-Surgery by Thomas Jefferson University, a Chief Medical Officer by Innovative Cellular Therapeutics, Inc., and a Trustee by The Hope Funds for Cancer Research.
He received his undergraduate degree from the University of Virginia and a doctorate degree from Medical College of Virginia.
Postes actifs de Eugene Kennedy
| Sociétés | Poste | Début |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Directeur Technique/Scientifique/R&D | 23/09/2025 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
The American Association of Cancer Research | Corporate Officer/Principal | - |
Anciens postes connus de Eugene Kennedy
| Sociétés | Poste | Fin |
|---|---|---|
| GALERA T COM USD0. | Directeur Technique/Scientifique/R&D | 01/09/2023 |
| LUMOS PHARMA, INC. | Directeur Technique/Scientifique/R&D | 06/03/2021 |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2013 |
| CARISMA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Innovative Cellular Therapeutics, Inc.
 Innovative Cellular Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cellular immunotherapies for the treatment of solid tumors | Directeur Technique/Scientifique/R&D | - |
Formation de Eugene Kennedy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
 Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services Provides funds for cancer research | Commercial Services |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
Innovative Cellular Therapeutics, Inc.
Innovative Cellular Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cellular immunotherapies for the treatment of solid tumors | Health Technology |
The American Association of Cancer Research | |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
